Literature DB >> 10569801

Estrogen-induced pituitary tumor development in the ACI rat not inhibited by dietary energy restriction.

T J Spady1, K L Pennington, R D McComb, D F Birt, J D Shull.   

Abstract

We have demonstrated that a 40% restriction of dietary energy consumption virtually abolishes the development of prolactin (PRL)-producing pituitary tumors in Fischer 344 (F344) rats treated chronically with estrogen, apparently by inhibiting the ability of estrogen to enhance survival within a rapidly proliferating lactotroph population. The purpose of the study reported here was to determine whether energy restriction exerts a similar antitumorigenic action in another rat strain, August x Copenhagen-Irish (ACI), in which PRL-producing pituitary tumors develop in response to estrogen treatment. Ovariectomized female ACI rats were either allowed to consume a control diet ad libitum or were fed a modified diet that restricted energy consumption by 40% relative to the amount of energy consumed by animals fed the control diet. We also examined the ability of 17beta-estradiol (E2) administered for 20 wk via subcutaneous Silastic implants to induce development of PRL-producing pituitary tumors. Treatment with E2 increased pituitary weight as well as the pituitary weight-to-body weight ratio and induced gross hyperprolactinemia to the same extent in ACI rats fed either the control or the energy-restricted diet. Moreover, dietary energy restriction did not affect the ability of E2 to induce pituitary cell proliferation or inhibit apoptosis, as evidenced by quantification of two surrogate markers. These data provide compelling evidence that a 40% restriction of energy consumption does not inhibit the ability of E2 to induce pituitary tumor development in the ACI rat. In conjunction with our published studies of the F344 rat strain, the data presented herein indicate that the inhibitory effects of dietary energy restriction on estrogen-induced pituitary tumor development are rat-strain specific and suggest that sensitivity to specific antitumorigenic actions of energy restriction is strongly affected by genetic background. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10569801

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  9 in total

1.  Genetic mapping of loci controlling diethylstilbestrol-induced thymic atrophy in the Brown Norway rat.

Authors:  Karen A Gould; Tracy E Strecker; Kimberly K Hansen; Kimberly K Bynoté; Kelli A Peterson; James D Shull
Journal:  Mamm Genome       Date:  2006-05       Impact factor: 2.957

2.  Ept7 influences estrogen action in the pituitary gland and body weight of rats.

Authors:  Scott G Kurz; Kirsten L Dennison; Nyssa Becker Samanas; Maureen Peters Hickman; Quincy A Eckert; Tiffany L Walker; Andrea S Cupp; James D Shull
Journal:  Mamm Genome       Date:  2014-01-22       Impact factor: 2.957

3.  Genetic mapping of Eutr1, a locus controlling E2-induced pyometritis in the Brown Norway rat, to RNO5.

Authors:  Karen A Gould; Jyotsna Pandey; Cynthia M Lachel; Clare R Murrin; Lisa A Flood; Karen L Pennington; Beverly S Schaffer; Martin Tochacek; Rodney D McComb; Jane L Meza; Douglas L Wendell; James D Shull
Journal:  Mamm Genome       Date:  2005-11-11       Impact factor: 2.957

Review 4.  Estrogen action in the regulation of cell proliferation, cell survival, and tumorigenesis in the rat anterior pituitary gland.

Authors:  T J Spady; R D McComb; J D Shull
Journal:  Endocrine       Date:  1999-12       Impact factor: 3.633

5.  Genetic bases of estrogen-induced pituitary tumorigenesis: identification of genetic loci determining estrogen-induced pituitary growth in reciprocal crosses between the ACI and Copenhagen rat strains.

Authors:  Tracy E Strecker; Thomas J Spady; Beverly S Schaffer; Karen A Gould; Amy E Kaufman; Fangchen Shen; Mac T McLaughlin; Karen L Pennington; Jane L Meza; James D Shull
Journal:  Genetics       Date:  2005-01-31       Impact factor: 4.562

6.  Development and characterization of a novel rat model of estrogen-induced mammary cancer.

Authors:  Kirsten L Dennison; Nyssa Becker Samanas; Quincy Eckert Harenda; Maureen Peters Hickman; Nicole L Seiler; Lina Ding; James D Shull
Journal:  Endocr Relat Cancer       Date:  2015-04       Impact factor: 5.678

7.  Genetic control of estrogen action in the rat: mapping of QTLs that impact pituitary lactotroph hyperplasia in a BN x ACI intercross.

Authors:  James D Shull; Cynthia M Lachel; Clare R Murrin; Karen L Pennington; Beverly S Schaffer; Tracy E Strecker; Karen A Gould
Journal:  Mamm Genome       Date:  2007-09-18       Impact factor: 2.957

8.  Rat strain specific attenuation of estrogen action in the anterior pituitary gland by dietary energy restriction.

Authors:  Djuana M E Harvell; Linda K Buckles; Karen A Gould; Karen L Pennington; Rodney D McComb; James D Shull
Journal:  Endocrine       Date:  2003-07       Impact factor: 3.633

9.  Tamoxifen induces regression of estradiol-induced mammary cancer in the ACI.COP-Ept2 rat model.

Authors:  Rachel L Ruhlen; Dana M Willbrand; Cynthia L Besch-Williford; Lixin Ma; James D Shull; Edward R Sauter
Journal:  Breast Cancer Res Treat       Date:  2008-09-09       Impact factor: 4.872

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.